Phesgo or trastuzumab and pertuzumab

Trastuzumab administration during pregnancy: an update trastuzumab In 2006, trastuzumab plus chemotherapy was approved to treat patients after their HER2-overexpressing breast tumors were surgically removed trastuzumab Trastuzumab, a humanized monoclonal antibody against the ectodomain of HER2 Trastuzumab uses multiple mechanisms to interfere with HER2 downstream

trastuzumab Common side effects of pertuzumab and trastuzumab · Risk of infection · Bruising and bleeding · Anaemia · Effects on the heart